Littérature scientifique sur le sujet « Biliary secretion »
Créez une référence correcte selon les styles APA, MLA, Chicago, Harvard et plusieurs autres
Consultez les listes thématiques d’articles de revues, de livres, de thèses, de rapports de conférences et d’autres sources académiques sur le sujet « Biliary secretion ».
À côté de chaque source dans la liste de références il y a un bouton « Ajouter à la bibliographie ». Cliquez sur ce bouton, et nous générerons automatiquement la référence bibliographique pour la source choisie selon votre style de citation préféré : APA, MLA, Harvard, Vancouver, Chicago, etc.
Vous pouvez aussi télécharger le texte intégral de la publication scolaire au format pdf et consulter son résumé en ligne lorsque ces informations sont inclues dans les métadonnées.
Articles de revues sur le sujet "Biliary secretion"
Blot-Chabaud, M., M. Dumont, M. Corbic et S. Erlinger. « Effect of acid-base balance on biliary bicarbonate secretion in the isolated perfused guinea pig liver ». American Journal of Physiology-Gastrointestinal and Liver Physiology 258, no 6 (1 juin 1990) : G863—G872. http://dx.doi.org/10.1152/ajpgi.1990.258.6.g863.
Texte intégralUc, Aliye, Radhamma Giriyappa, David K. Meyerholz, Michelle Griffin, Lynda S. Ostedgaard, Xiao Xiao Tang, Marwa Abu-El-Haija et al. « Pancreatic and biliary secretion are both altered in cystic fibrosis pigs ». American Journal of Physiology-Gastrointestinal and Liver Physiology 303, no 8 (15 octobre 2012) : G961—G968. http://dx.doi.org/10.1152/ajpgi.00030.2012.
Texte intégralSætre, S. S., N. J. Andersen, T. Houe, P. Svendsen, J. F. Rehfeld, O. Olsen et O. B. Schaffalitzky de Muckadell. « Regulation of porcine biliary secretion by secretin ». Acta Physiologica Scandinavica 163, no 1 (mai 1998) : 113–19. http://dx.doi.org/10.1046/j.1365-201x.1998.00349.x.
Texte intégralAlpini, G., R. Lenzi, W. R. Zhai, P. A. Slott, M. H. Liu, L. Sarkozi et N. Tavoloni. « Bile secretory function of intrahepatic biliary epithelium in the rat ». American Journal of Physiology-Gastrointestinal and Liver Physiology 257, no 1 (1 juillet 1989) : G124—G133. http://dx.doi.org/10.1152/ajpgi.1989.257.1.g124.
Texte intégralZeniya, M., et A. Reuben. « Triton WR-1339-induced changes in serum lipids and biliary lipid secretion ». American Journal of Physiology-Gastrointestinal and Liver Physiology 254, no 3 (1 mars 1988) : G346—G354. http://dx.doi.org/10.1152/ajpgi.1988.254.3.g346.
Texte intégralHofmann, Alan F. « Biliary Secretion : Future Perspectives ». Digestion 58, no 1 (1997) : 24–28. http://dx.doi.org/10.1159/000201519.
Texte intégralReuben, A., P. N. Maton, G. M. Murphy et R. H. Dowling. « Bile Lipid Secretion in Obese and Non-Obese Individuals with and without Gallstones ». Clinical Science 69, no 1 (1 juillet 1985) : 71–79. http://dx.doi.org/10.1042/cs0690071.
Texte intégralChanussot, F., H. Lafont, J. Hauton, B. Tuchweber et I. Yousef. « Studies on the origin of biliary phospholipid. Effect of dehydrocholic acid and cholic acid infusions on hepatic and biliary phospholipids ». Biochemical Journal 270, no 3 (15 septembre 1990) : 691–95. http://dx.doi.org/10.1042/bj2700691.
Texte intégralHan, Yuyan, Paolo Onori, Fanyin Meng, Sharon DeMorrow, Julie Venter, Heather Francis, Antonio Franchitto et al. « Prolonged exposure of cholestatic rats to complete dark inhibits biliary hyperplasia and liver fibrosis ». American Journal of Physiology-Gastrointestinal and Liver Physiology 307, no 9 (1 novembre 2014) : G894—G904. http://dx.doi.org/10.1152/ajpgi.00288.2014.
Texte intégralVerkade, H. J., R. Havinga, A. Gerding, R. J. Vonk et F. Kuipers. « Mechanism of bile acid-induced biliary lipid secretion in the rat : effect of conjugated bilirubin ». American Journal of Physiology-Gastrointestinal and Liver Physiology 264, no 3 (1 mars 1993) : G462—G469. http://dx.doi.org/10.1152/ajpgi.1993.264.3.g462.
Texte intégralThèses sur le sujet "Biliary secretion"
Baxter, Debbie Jane. « Molecular mechanisms of biliary lipid secretion ». Thesis, Liverpool John Moores University, 1999. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.298908.
Texte intégralMareux, Elodie. « Pharmacothérapie ciblée des déficits en ABCB11 ». Electronic Thesis or Diss., université Paris-Saclay, 2021. http://www.theses.fr/2021UPASL083.
Texte intégralABCB11/BSEP (Bile Salt Export Pump) is expressed at the canalicular membrane of hepatocytes. It ensures bile acids secretion into bile which is essential for biliary secretion. Nearly 400 variations of the ABCB11 gene have been identified and are associated with rare hepatobiliary diseases, the most severe being progressive familial intrahepatic cholestasis type 2 (PFIC2). The effectiveness of medical treatments is limited. Consequently, liver transplantation is required before adulthood for almost 2/3 of PFIC2 patients. In this context, the identification of alternative therapies is a major challenge.This thesis focuses on personalized therapeutic strategies to correct the pathological consequences of some ABCB11 variations identified in patients. The A257V, G562D and T463I variations of ABCB11 were studied by 3D molecular modelling. These variations were responsible for a defect in Abcb11 transport function. Ivacaftor (VX-770, Kalydeco®), a clinically approved cystic fibrosis treatment, corrects the activity defect of the three variants.Similar effects were observed with GLPG1837, SBC040 and SBC219, known as potentiators of CFTR (Cystic Fibrosis Transmembrane Conductance Regulator).From a combinatory therapy perspective, we also demonstrated the ability of these potentiators to correct the transport defect of the R1090C and R1090W variants, potential readthrough products of the R1090X nonsense variant. We also evaluated the ability of Elexacaftor (VX-445) and Tezacaftor (VX 661) correctors of CFTR. These correctors, alone or in combination, restored trafficking of the R1128C missense variant, leading to a significant increase in the transport function. Interestingly, the addition of potentiators abolishes this effect.Altogether, this thesis constitutes a proof of concept that molecules with high therapeutic potential can correct the molecular defects of ABCB11 variants. These treatments could increase the pharmacopoeia available for patients with ABCB11 deficiency and thus delay or even suppress the need for liver transplantation
LANGLOIS, ANNIK. « Contribution a l'etude de la regulation hormonale des secretions digestives chez le porc : effets du polypeptide pancreatique sur la secretion pancreatique exocrine et la secretion biliaire chez l'animal conscient ». Paris 7, 1989. http://www.theses.fr/1989PA077080.
Texte intégralLam, Pak-yan Ian, et 林柏炘. « Secretin in biliary physiology : autocrine regulation on cholangiocyte proliferation and negative feedbackregulation on duodenal secretin expression via bile acids ». Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2009. http://hub.hku.hk/bib/B43572327.
Texte intégralLam, Pak-yan Ian. « Secretin in biliary physiology autocrine regulation on cholangiocyte proliferation and negative feedback regulation on duodenal secretin expression via bile acids / ». Click to view the E-thesis via HKUTO, 2009. http://sunzi.lib.hku.hk/hkuto/record/B43572327.
Texte intégralZanninelli, Giuliana. « Effets de chelateurs sur le routage cellulaire du fer non lie a la transferrine (doctorat : biologie et sciences de la sante) ». Rennes 1, 2000. http://www.theses.fr/2000REN1B044.
Texte intégralDupuy-Esnault, Christine. « Relation entre le cholestérol libre des HDL et des LDL et la secretion biliaire du cholestérol et des sels biliaires : influence de divers régimes hyperlipidiques ». Aix-Marseille 2, 1986. http://www.theses.fr/1986AIX22066.
Texte intégralBruneau, Alix. « Régulation de l'expression membranaire du transporteur de phospholipides biliaires ABCB4 : effet de mutations Functional Defect of Variants in the Adenosine Triphosphate–Binding Sites of ABCB4 and Their Rescue by the Cystic Fibrosis Transmembrane Conductance Regulator Potentiator, Ivacaftor (VX-770) Structural analogues of roscovitine rescue the intracellular traffic and the function of ER-retained ABCB4 variants in cell models ». Thesis, Sorbonne université, 2019. http://www.theses.fr/2019SORUS048.
Texte intégralABCB4 is exclusively expressed at the canalicular membrane of hepatocytes where its function is to translocate phosphatidylcholine (PC) into bile. Variations in ABCB4 gene sequence are associated with several chronic and progressive liver diseases. The most severe is PFIC3 which develops early in childhood and most often requires liver transplantation. Less severe diseases are the intrahepatic cholestasis of pregnancy and the low phospholipid- associated cholelithiasis syndrome which occur in young adults. Up to now, about 500 disease-causing ABCB4 variants have been reported. A challenge is to find pharmacological treatments for the severe forms of the diseases. We have studied the effect of five disease-causing variations that reside in the highly conserved motifs of ABC transporters, involved in ATP binding. Using three-dimension structural modeling and in vitro studies, we showed that the five mutants were normally processed and targeted to the plasma membrane, whereas their PC secretion activity was dramatically decreased. PC secretion activity of the mutants was rescued by the clinically approved CFTR potentiator ivacaftor (VX-770). These results pave the way for personalized therapy in ABCB4-related diseases.The second part of my project was aimed at investigating the potential role of two ABCB4 partners, the kinase MRCKalpha and its effector the myosin light chain II (MLCII) in the expression and function of ABCB4. We found that downregulation of both partners didn’t affect the canalicular localization of ABCB4 but led to a reduction of its endocytosis. Our results open new insights into the mechanisms underlying the regulation of ABCB4 expression and function
Sutherland, Jessica Elin. « The kinetics of absorption, tissue distribution, biliary secretion, and urinary excretion of ingested aluminum ». 1997. http://catalog.hathitrust.org/api/volumes/oclc/40160453.html.
Texte intégralMustacich, Debbie J. « The microtubule system and the canalicular mdr2 P-glycoprotein play a role in the intracellular transport and biliary secretion of ��-Tocopherol and phosphatidylcholine in rats and mice ». Thesis, 1998. http://hdl.handle.net/1957/34062.
Texte intégralLivres sur le sujet "Biliary secretion"
Hamlin, Sandra Mary. Modulation of biliary lipid secretion. Birmingham : University of Birmingham, 1990.
Trouver le texte intégralMustacich, Debbie J. The microtubule system and the canalicular mdr2 P-glycoprotein play a role in the intracellular transport and biliary secretion of Ü-Tocopherol and phosphatidylcholine in rats and mice. 1998.
Trouver le texte intégralChapitres de livres sur le sujet "Biliary secretion"
Zimniak, Piotr, et Roger Lester. « Disorders of Biliary Secretion ». Dans Molecular Biology of Membrane Transport Disorders, 519–39. Boston, MA : Springer US, 1996. http://dx.doi.org/10.1007/978-1-4613-1143-0_26.
Texte intégralCarulli, Nicola, Paola Loria, Marco Bertolotti et Alberto Tripodi. « Determinants of Biliary Cholesterol Secretion ». Dans Assessment and Management of Hepatobiliary Disease, 49–58. Berlin, Heidelberg : Springer Berlin Heidelberg, 1987. http://dx.doi.org/10.1007/978-3-642-72631-6_7.
Texte intégralColeman, R., K. L. Rahman, M. E. Bellringer et M. Carrella. « Biliary Lipid Secretion and its Control ». Dans Bile Acids in Health and Disease, 43–60. Dordrecht : Springer Netherlands, 1988. http://dx.doi.org/10.1007/978-94-009-1249-6_4.
Texte intégralKuipers, Folkert, Ronald P. J. Oude Elferink, Henkjan J. Verkade et Albert K. Groen. « Mechanisms and (Patho)Physiological Significance of Biliary Cholesterol Secretion ». Dans Subcellular Biochemistry, 295–318. Boston, MA : Springer US, 1997. http://dx.doi.org/10.1007/978-1-4615-5901-6_11.
Texte intégralLirussi, F., et L. Okolicsanyi. « The Effect of Drugs on Liver Function and Biliary Secretion ». Dans Biochemical Pharmacology as an Approach to Gastrointestinal Disorders, 239–47. Dordrecht : Springer Netherlands, 1997. http://dx.doi.org/10.1007/978-94-011-5390-4_19.
Texte intégralBarbara, L., G. Mazzella, N. Villanova, P. Simoni, M. Ronchi, A. Roda, E. Roda et F. Bazzoli. « Effect of Gemfibrozil Administration on Biliary Lipid Secretion : A Crossover Study with Clofibrate ». Dans Drugs Affecting Lipid Metabolism, 350–54. Berlin, Heidelberg : Springer Berlin Heidelberg, 1987. http://dx.doi.org/10.1007/978-3-642-71702-4_65.
Texte intégralBentham Science Publisher, Bentham Science Publisher. « Biliary Secretion ». Dans FFunctional Molecular Imaging In Hepatology (Open Access), 49–75. BENTHAM SCIENCE PUBLISHERS, 2012. http://dx.doi.org/10.2174/978160805290511201010049.
Texte intégralPal, Gopal, Pravati Pal et Nivedita Nanda. « Biliary Secretion ». Dans Comprehensive Textbook of Medical Physiology (Volume 1), 378. Jaypee Brothers Medical Publishers (P) Ltd., 2017. http://dx.doi.org/10.5005/jp/books/12960_43.
Texte intégralFeher, Joseph. « Pancreatic and Biliary Secretion ». Dans Quantitative Human Physiology, 810–20. Elsevier, 2017. http://dx.doi.org/10.1016/b978-0-12-800883-6.00080-x.
Texte intégralMiller, Laurence J. « Gallbladder and Biliary Secretion ». Dans Encyclopedia of Endocrine Diseases, 94–96. Elsevier, 2004. http://dx.doi.org/10.1016/b0-12-475570-4/00497-2.
Texte intégral